Stay updated on Neoadj. Encorafenib/Binimetinib in Melanoma: Clinical Trial
Sign up to get notified when there's something new on the Neoadj. Encorafenib/Binimetinib in Melanoma: Clinical Trial page.

Latest updates to the Neoadj. Encorafenib/Binimetinib in Melanoma: Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedA new 'Study Status' entry was added to the Record History (dated 2026-02-11). Version 17 appears (dated 2026-01-23), and the 2026-01-20 entry was removed.SummaryDifference0.3%

- Check20 days agoChange DetectedRevision: v3.4.2 was added to the history, and older notices (the funding lapse notice and Revision: v3.4.1) were removed. These changes are administrative and do not alter trial data or study records.SummaryDifference0.7%

- Check27 days agoChange DetectedAdded a government funding notice about potential delays and the NIH Clinical Center’s operating status, and updated the page history with Revision v3.4.1 (removing v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check34 days agoChange DetectedUI/formatting updates to the history page (glossary toggle, color-coded change indicators, and revision notes) without altering study content, status, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.9%

- Check41 days agoChange DetectedThe 2026-01-20 update adds Adverse Events, Outcome Measures (Results), Participant Flow, and Study Status to the record history. A previous version was removed on 2025-11-24.SummaryDifference0.6%

- Check48 days agoChange DetectedThe page history now includes Revision: v3.3.4 and removes Revision: v3.3.3, reflecting a minor maintenance update; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Neoadj. Encorafenib/Binimetinib in Melanoma: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Neoadj. Encorafenib/Binimetinib in Melanoma: Clinical Trial page.